First-trimester screening for trisomy 21 in Denmark: Implications for detection and birth rates of trisomy 18 and trisomy 13

Ultrasound in Obstetrics and Gynecology

Volumn 38, Issue 2, 2011, Pages 140-144

  Ekelund, C K ^a   Petersen, O B ^b   Skibsted, L ^c,d   Kjaergaard, S ^a   Vogel, I ^b   Tabor, A ^a,d  

^a Rigshospitalet   (Denmark)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

^c ROSKILDE HOSPITAL   (Denmark)

^d UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

birth rates; Down syndrome; first trimester screening; trisomy 13; trisomy 18

Indexed keywords

BIOLOGICAL MARKER; CHORIONIC GONADOTROPIN BETA SUBUNIT;

ADULT; ARTICLE; BIRTH RATE; BLOOD; CHROMOSOME 13; CHROMOSOME 18; CHROMOSOME DISORDER; DENMARK; DOWN SYNDROME; FEMALE; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HUMAN; MATERNAL AGE; METHODOLOGY; NUCHAL TRANSLUCENCY MEASUREMENT; PATAU SYNDROME; PRACTICE GUIDELINE; PREGNANCY; PRENATAL DIAGNOSIS; TRISOMY;

ADULT; BIOLOGICAL MARKERS; BIRTH RATE; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; CHROMOSOME DISORDERS; CHROMOSOMES, HUMAN, PAIR 13; CHROMOSOMES, HUMAN, PAIR 18; DENMARK; DOWN SYNDROME; FEMALE; GESTATIONAL AGE; GUIDELINES AS TOPIC; HUMANS; MATERNAL AGE; NUCHAL TRANSLUCENCY MEASUREMENT; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PRENATAL DIAGNOSIS; TRISOMY;

EID: 80051723514     PISSN: 09607692     EISSN: 14690705     Source Type: Journal    
DOI: 10.1002/uog.8929     Document Type: Article

References (22)

1. Morris JK, Savva GM,. The risk of fetal loss following a prenatal diagnosis of trisomy 13 or trisomy 18. Am J Med Genet A 2008; 146: 827-832. (Pubitemid 351499786)
2. Goldstein H, Nielsen KG,. Rates and survival of individuals with trisomy 13 and 18. Data from a 10-year period in Denmark. Clin Genet 1988; 34: 366-372. (Pubitemid 19008727)
3. Parker MJ, Budd JL, Draper ES, Young ID,. Trisomy 13 and trisomy 18 in a defined population: epidemiological, genetic and prenatal observations. Prenat Diagn 2003; 23: 856-860. (Pubitemid 37279874)
4. Rasmussen SA, Wong LY, Yang Q, May KM, Friedman JM,. Population-based analyses of mortality in trisomy 13 and trisomy 18. Pediatrics 2003; 111: 777-784. (Pubitemid 36402901)
5. Spencer K,. Aneuploidy screening in the first trimester. Am J Med Genet C Semin Med Genet 2007; 145C: 18-32. (Pubitemid 46427651)
6. Kagan KO, Etchegaray A, Zhou Y, Wright D, Nicolaides KH,. Prospective validation of first-trimester combined screening for trisomy 21. Ultrasound Obstet Gynecol 2009; 34: 14-18.
7. Nicolaides KH, Spencer K, Avgidou K, Faiola S, Falcon O,. Multicenter study of first-trimester screening for trisomy 21 in 75 821 pregnancies: results and estimation of the potential impact of individual risk-orientated two-stage first-trimester screening. Ultrasound Obstet Gynecol 2005; 25: 221-226. (Pubitemid 40432687)
8. Malone FD, Canick JA, Ball RH, Nyberg DA, Comstock CH, Bukowski R, Berkowitz RL, Gross SJ, Dugoff L, Craigo SD, Timor-Tritsch IE, Carr SR, Wolfe HM, Dukes K, Bianchi DW, Rudnicka AR, Hackshaw AK, Lambert-Messerlian G, Wald NJ, D'Alton ME,. First-trimester or second-trimester screening, or both, for Down's syndrome. N Engl J Med 2005; 353: 2001-2011. (Pubitemid 41609093)
9. Snijders RJ, Noble P, Sebire N, Souka A, Nicolaides KH,. UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10-14 weeks of gestation. Fetal Medicine Foundation First Trimester Screening Group. Lancet 1998; 352: 343-346. (Pubitemid 28352196)
10. Ekelund CK, Jorgensen FS, Petersen OB, Sundberg K, Tabor A,. Impact of a new national screening policy for Down's syndrome in Denmark: population based cohort study. BMJ 2008; 337: a2547.
11. Kagan KO, Wright D, Valencia C, Maiz N, Nicolaides KH,. Screening for trisomies 21, 18 and 13 by maternal age, fetal nuchal translucency, fetal heart rate, free beta-hCG and pregnancy-associated plasma protein-A. Hum Reprod 2008; 23: 1968-1975.
12. Kagan KO, Wright D, Maiz N, Pandeva I, Nicolaides KH,. Screening for trisomy 18 by maternal age, fetal nuchal translucency, free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A. Ultrasound Obstet Gynecol 2008; 32: 488-492.
13. Ekelund CK, Andersen HJ, Christensen J, Ersbak V, Farlie R, Henriques C, Holmskov A, Jensen LN, Jorgensen FS, Hessellund A, Larsen T, Olesen AW, Pedersen OB, Poulsen H, Ramb J, Skibsted L, Skovbo P, Sommer S, Sperling L, Sundberg K, Juul SV, Zingenberg H, Tabor A,. [Down's syndrome risk assessment in Denmark-secondary publication]. Ugeskr Laeger 2010; 172: 1759-1761.
14. Snijders RJ, Holzgreve W, Cuckle H, Nicolaides KH,. Maternal age-specific risks for trisomies at 9-14 weeks' gestation. Prenat Diagn 1994; 14: 543-552. (Pubitemid 24234883)
15. Spencer K, Nicolaides KH,. A first trimester trisomy 13/trisomy 18 risk algorithm combining fetal nuchal translucency thickness, maternal serum free beta-hCG and PAPP-A. Prenat Diagn 2002; 22: 877-879. (Pubitemid 35175986)
16. Breathnach FM, Malone FD, Lambert-Messerlian G, Cuckle HS, Porter TF, Nyberg DA, Comstock CH, Saade GR, Berkowitz RL, Klugman S, Dugoff L, Craigo SD, Timor-Tritsch IE, Carr SR, Wolfe HM, Tripp T, Bianchi DW, D'Alton ME,. First- and second-trimester screening: detection of aneuploidies other than Down syndrome. Obstet Gynecol 2007; 110: 651-657. (Pubitemid 47359591)
17. Jaques AM, Halliday JL, Francis I, Bonacquisto L, Forbes R, Cronin A, Sheffield LJ,. Follow up and evaluation of the Victorian first-trimester combined screening programme for Down syndrome and trisomy 18. BJOG 2007; 114: 812-818. (Pubitemid 46918692)
18. Kirkegaard I, Petersen OB, Uldbjerg N, Torring N,. Performance of first-trimester combined screening for trisomy 13 and 18 with the double test taken at a gestational age of 8 + 0 to 13 + 6. Prenat Diagn 2009; 29: 582-587.
19. Shipp TD, Benacerraf BR,. Second trimester ultrasound screening for chromosomal abnormalities. Prenat Diagn 2002; 22: 296-307. (Pubitemid 34498766)
20. de Graaf IM, Tijmstra T, Bleker OP, van Lith JM,. Womens' preference in Down syndrome screening. Prenat Diagn 2002; 22: 624-629. (Pubitemid 34839304)
21. Bartlett LA, Berg CJ, Shulman HB, Zane SB, Green CA, Whitehead S, Atrash HK,. Risk factors for legal induced abortion-related mortality in the United States. Obstet Gynecol 2004; 103: 729-737. (Pubitemid 40459035)
22. Vendola C, Canfield M, Daiger SP, Gambello M, Hashmi SS, King T, Noblin SJ, Waller DK, Hecht JT,. Survival of Texas infants born with trisomies 21, 18, and 13. Am J Med Genet A 2010; 152A: 360-366.